Dr. Tessa Cigler, M.D., M.P.H.
Board Member
Atossa Therapeutics, Inc. (ATOS)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Tessa Cigler, M.D., M.P.H.
Dr. Tessa Cigler, M.D., M.P.H. is recorded as Board Member at Atossa Therapeutics, Inc. (ATOS). Atossa Therapeutics, Inc. reported in an 8-K filed March 12, 2024 that Dr. Tessa Cigler, M.D., M.P.H. was appointed Class II director, effective March 9, 2024.
“On March 9, 2024, the Board of Directors (the "Board") of Atossa Therapeutics, Inc. (the "Company") expanded its size and appointed Dr. Tessa Cigler, M.D., M.P.H. as a Class II director to hold office until the 2026 Annual Meeting of Stockholders and until her successor shall have been duly elected and qualified, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-03-09–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Atossa Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Steven Quay CEO
- Greg Weaver CFO
- Mark Daniel CFO, Chief Accounting Officer
- Mark J. Daniel CFO
- H. Lawrence Remmel, Esq. Board Member
- Jonathan Finn Board Member
- Jonathan Finn, CFA Board Member
- Shu-Chih Chen Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.